Wanda French-Brown is an accomplished litigator who brings a creative and analytical approach to each matter, focusing on the overall picture to develop litigation strategies that align with her clients’ business objectives.
French-Brown has represented clients in patent infringement matters in federal courts, the U.S. International Trade Commission, and Patent Trial and Appeal Board.
French-Brown has broad technological knowledge, regularly representing clients in a range of technologies, including wireless communication and mobile devices, LCD and LED, biotechnology, medical devices, health care diagnostics, and pharmaceuticals with a concentration in Hatch-Waxman litigation.
With a decade of experience working as a registered pharmacist in the health care and pharmaceutical fields, French-Brown is well-versed in Food and Drug Administration guidelines created by the Hatch-Waxman and Biologics Price Competition and Innovation acts, which are crucial to the entry of generic and biosimilar pharmaceutical products.
French-Brown holds a B.S. from Rutgers University College of Pharmacy and a J.D. from Seton Hall University Law School.
